Dapagliflozin Efficacy and Action in PCOS

Phase 3 Completed 165 enrolled Nanfang Hospital, Southern Medical University

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of dapagliflozin on improving insulin resistance and hyperandrogenemia in obesity women with polycystic ovary syndrome.

Timeline

Start: 2020-03-20
Primary completion: 2022-10-01
Completion: 2022-11-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dapagliflozin	Small molecule	10 mg	Oral

Dapagliflozin Efficacy and Action in PCOS

Summary

Timeline

Drugs

Indications